Alec Machiels - Nov 4, 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Alec Machiels
Stock symbol
APLS
Transactions as of
Nov 4, 2021
Transactions value $
-$219,480
Form type
4
Date filed
11/17/2021, 04:01 PM
Previous filing
Aug 17, 2021
Next filing
Dec 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $8.01K +3K +0.45% $2.67* 673K Nov 4, 2021 Direct F1
transaction APLS Common Stock Sale -$105K -3K -0.45% $35.00 670K Nov 4, 2021 Direct F1
transaction APLS Common Stock Options Exercise $8.01K +3K +0.45% $2.67* 673K Nov 15, 2021 Direct F1
transaction APLS Common Stock Sale -$131K -3K -0.45% $43.50 670K Nov 15, 2021 Direct F1
holding APLS Common Stock 1.95K Nov 4, 2021 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -3K -2.18% $0.00 135K Nov 4, 2021 Common Stock 3K $2.67 Direct F1, F3
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -3K -2.23% $0.00 132K Nov 15, 2021 Common Stock 3K $2.67 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise and sale from 10B5-1 trading plan.
F2 Owned by spouse.
F3 This option was granted on December 5, 2013 and fully vested.